Webster co-authors book on immune aspects of biopharmaceuticals and nanomedicines
BMES fellow Thomas Webster co-authored a new book that examines and provides a broad survey of various topics pertaining to the immune effects of biopharmaceuticals and nanomedicines, both beneficial and adverse.
The book is designed to be a reference for the novice and expert alike in diverse areas such as medicine, law, biotechnology, nanotechnology, pharmaceutical sciences, toxicology, drug development, regulatory science, and governmental affairs.
It highlights both cutting-edge technological advances and also addresses critical topics such as nano-bio interactions, toxicity, and FDA regulatory issues.
The other authors include: Raj Bawa, Janos Szebeni and Gerald F. Audette.
The book provides a broad survey of various interconnected topics, all accomplished in a user&friendly format. The chapters are devoted to the immune stimulatory and suppressive effects of antibodies, peptides and other biopharmaceuticals, drug carrier liposomes, micelles, polymers, polymeric vesicles, dendrimers, carbon nanotubes, and other nanomedicines (with and without surface targeting ligands).
For more information CLICK HERE.